N/A
N=10
Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment
Vaccine Response Impaired
Bottom Line
View on ClinicalTrials.gov: NCT02453113 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcome: Primary: Change in Skin Tissue Response to a Vaccine — 39.0; 36.1; 21.5; 11.8 Total number of CD1a+ cells (5hpf)
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- low power laser (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of California, Irvine
- Primary completion
- Jan 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Skin Tissue Response to a Vaccine |
39.0; 36.1; 21.5; 11.8 | — |
Summary
The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve the human skin immune system to help improve human body response to vaccines.
Eligibility Criteria
Inclusion Criteria
- Adult men and women with skin type 1 and 2
- Not pregnant
Exclusion Criteria
- Use of systemic steroids, topical steroids, tanning solutions and anticoagulant
- History of HIV, mentally incompetent, prisoner, alcohol or drug impairment
- Abnormal photosensitivity
Data sourced from ClinicalTrials.gov (NCT02453113). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.